Hebecell Corp
HebeCell, established in April of 2016, will become an important player in the fields of Immuno-Oncology & Regenerative Medicine. Our missions are:
1) To develop and commercialize cell-based therapeutics for incurable diseases;
2) To further explore and transform the infinite potentials of pluripotent stem cells into best-in-class products for the health of human beings.
Platform Technology:
Scalable 3D-bioreactor for human pluripotent stem cell (PSC) expansion and lineage specific differentiation. Based on this platform:
1. Immuno-Oncology Program---Off-The-Shelf PSC-CAR-NK Cells
2. Ocular Program---Photoreceptor Progenitors
3. NanoNeuron Therapeutics
Hebecell成立于2016年四月份,目标是成为免疫肿瘤学和再生医学领域的重要参与者。我们的使命是:
1)开发和商业化针对疑难杂症的细胞疗法;
2)进一步探索和转化多能干细胞的无限潜能成为人类健康的最佳产品。
平台技术:可扩展的3D生物反应器,用于人类多能干细胞(PSC)扩增和谱系特异性分化。基于这个平台:
1. 免疫肿瘤学项目---现成的PSC-CAR-NK细胞
2. 眼部项目---光感受器祖细胞
3. NanoNeuron Therapeutics